Literature DB >> 18179313

Personality and gender differences in effects of d-amphetamine on risk taking.

Tara L White1, C W Lejuez, Harriet de Wit.   

Abstract

The effects of stimulant drugs on risk-taking behavior vary across individuals, even in healthy samples. These differences could relate to personality, which may share common mechanisms with drug effects or impulsive, risk-taking behavior. The current study investigated the role of temperament and gender in the effects of amphetamine on risk taking. Forty healthy men and women, aged 18 to 35, completed the Balloon Analogue Risk Task (BART; Lejuez et al., 2002) with three reward values after ingesting placebo or d-amphetamine (10, 20 mg). They completed the Multidimensional Personality Questionnaire Brief Form (MPQ-BF; Patrick et al., 2002), with three main scales: Trait reward sensitivity (Agentic Positive Emotionality; AgPEM), impulsivity (Constraint; CON), and negative affect (Negative Emotionality; NEM). d-Amphetamine (20 mg) decreased risk behavior in low AgPEM males, but increased risk behavior in high AgPEM males, producing positive correlations with AgPEM in men (r >or= +.55, p<.05). The drug did not affect risk-taking in women. There was evidence of discriminant validity between the AgPEM, NEM, and CON dimensions and behavioral responses to amphetamine. Implications for treatment and addiction are discussed. (c) 2008 APA, all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18179313     DOI: 10.1037/1064-1297.15.6.599

Source DB:  PubMed          Journal:  Exp Clin Psychopharmacol        ISSN: 1064-1297            Impact factor:   3.157


  26 in total

1.  Effects of acute administration of nicotine, amphetamine, diazepam, morphine, and ethanol on risky decision-making in rats.

Authors:  Marci R Mitchell; Colin M Vokes; Amy L Blankenship; Nicholas W Simon; Barry Setlow
Journal:  Psychopharmacology (Berl)       Date:  2011-06-03       Impact factor: 4.530

2.  Psychostimulant drug effects on glutamate, Glx, and creatine in the anterior cingulate cortex and subjective response in healthy humans.

Authors:  Tara L White; Mollie A Monnig; Edward G Walsh; Adam Z Nitenson; Ashley D Harris; Ronald A Cohen; Eric C Porges; Adam J Woods; Damon G Lamb; Chelsea A Boyd; Sinda Fekir
Journal:  Neuropsychopharmacology       Date:  2018-03-06       Impact factor: 7.853

3.  Smoked cannabis' psychomotor and neurocognitive effects in occasional and frequent smokers.

Authors:  Nathalie A Desrosiers; Johannes G Ramaekers; Emeline Chauchard; David A Gorelick; Marilyn A Huestis
Journal:  J Anal Toxicol       Date:  2015-03-04       Impact factor: 3.367

4.  The effects of progesterone pretreatment on the response to oral d-amphetamine in Women.

Authors:  Stephanie C Reed; Frances R Levin; Suzette M Evans
Journal:  Horm Behav       Date:  2010-04-24       Impact factor: 3.587

5.  Behavioral characteristics and neural mechanisms mediating performance in a rodent version of the Balloon Analog Risk Task.

Authors:  James David Jentsch; Jason A Woods; Stephanie M Groman; Emanuele Seu
Journal:  Neuropsychopharmacology       Date:  2010-04-07       Impact factor: 7.853

6.  Sensitivity to cognitive effort mediates psychostimulant effects on a novel rodent cost/benefit decision-making task.

Authors:  Paul J Cocker; Jay G Hosking; James Benoit; Catharine A Winstanley
Journal:  Neuropsychopharmacology       Date:  2012-03-28       Impact factor: 7.853

7.  Pre-encoding administration of amphetamine or THC preferentially modulates emotional memory in humans.

Authors:  Michael E Ballard; David A Gallo; Harriet de Wit
Journal:  Psychopharmacology (Berl)       Date:  2012-12-09       Impact factor: 4.530

8.  Rate dependent effects of acute nicotine on risk taking in young adults are not related to ADHD diagnosis.

Authors:  Katherine K Ryan; Sarahjane L Dube; Alexandra S Potter
Journal:  Pharmacol Biochem Behav       Date:  2012-11-15       Impact factor: 3.533

9.  Test-retest characteristics of the Balloon Analogue Risk Task (BART).

Authors:  Tara L White; C W Lejuez; Harriet de Wit
Journal:  Exp Clin Psychopharmacol       Date:  2008-12       Impact factor: 3.157

10.  Impulsivity and risk taking in bipolar disorder and schizophrenia.

Authors:  L Felice Reddy; Junghee Lee; Michael C Davis; Lori Altshuler; David C Glahn; David J Miklowitz; Michael F Green
Journal:  Neuropsychopharmacology       Date:  2013-08-21       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.